Skip to content
Menu

Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $28

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Truist Securities analyst Ravi Misra maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target from $22 to $28.

Truist Securities analyst Ravi Misra maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target from $22 to $28.

Read at benzinga.com